Childhood predictors of young-onset type 2 diabetes

Paul W Franks1, Robert L Hanson, William C Knowler

  • 1Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1550 E. Indian School Rd., Phoenix, AZ 85014, USA.

Diabetes
|August 28, 2007
PubMed

Insights

Identifying early risk factors for type 2 diabetes in American Indian youth is crucial. A combination of fasting glucose, HDL cholesterol, and BMI effectively predicts diabetes risk, similar to a complex score.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Young-onset type 2 diabetes poses a significant health challenge.
  • Identifying early, modifiable risk factors is essential for effective prevention strategies.

Purpose of the Study:

  • To identify early-life modifiable risk factors for young-onset type 2 diabetes.
  • To evaluate the predictive power of various metabolic, anthropometric, and vascular traits.

Main Methods:

  • Longitudinal data from 1,604 American Indian children (ages 5-19) were analyzed.
  • A standardized multivariate score (zMS) was derived from multiple risk factors.
  • Cox proportional hazard models were used to assess diabetes prediction.

Main Results:

  • The zMS and its components (fasting glucose, 2-h glucose, HDL cholesterol, BMI) predicted type 2 diabetes.
  • A parsimonious score of fasting glucose, HDL cholesterol, and BMI showed similar predictive power to the zMS.
  • Familial risk factors did not alter the predictive magnitude of these scores.

Conclusions:

  • Childhood metabolic syndrome features, particularly obesity, glucose dysregulation, and low HDL cholesterol, are key predictors of type 2 diabetes.
  • Targeting these factors in childhood and adolescence is a promising prevention strategy.
  • A simplified risk score can effectively identify high-risk individuals.
Abstract

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...